ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: "Gyrodyne Company of America, Inc." (GYRO) Report Updated: Oct 27, 2014 | Print This Page

Get more stock ratings by Louis Navellier

"Gyrodyne Company of America, Inc." (GYRO)

Rating: Strong Sell Volatility: Moderate
Total Grade: F Industry: Real Estate Investment Trusts (REITs)
Competitors: ARI, RHP, FCH, KRC

Stock Analysis

Rating: Monthly View

A
B
C
D
F
November December January February March April May June July August September October

Rating: Weekly View

This Week: F down no change
Last Week: F same no change
Two Weeks Ago: F up no change
service keys

"Gyrodyne Company of America, Inc."© quotemedia

Company Profile

Gyrodyne Company of America, Inc., a real estate investment trust (REIT), engages in the investment, acquisition, ownership, and management of a portfolio of medical office and industrial properties in the northeast region of the United States. It is also involved in the development of industrial and residential properties. The company focuses on acquiring, developing, owning, leasing, and managing medical, commercial, and industrial real estate. As of March 31, 2012, it had 100% ownership in 3 medical office parks comprising approximately 131,000 rentable square feet; and 1 multitenant industrial park consisting of 128,000 rentable square feet, as well as approximately 68 acres of property in St. James, New York. The company has elected to be taxed as REIT under the Internal Revenue Code. As a REIT, it would not be subject to federal income tax purposes, provided that it distributes at least 90% of its taxable income to its shareholders. The company was founded in 1946 and is headquartered in St. James, New York.

Recent News: "Gyrodyne Company of America, Inc."